# OnCo record liquid-biopsy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/liquid-biopsy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "liquid-biopsy" ;
  schema:name "Liquid biopsy (ctDNA)"@en ;
  schema:description "A blood test that reads fragments of DNA shed by the tumour, so you can genotype or monitor cancer without a needle in the tumour."@en ;
  schema:url <https://onco.cc/technologies/liquid-biopsy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Liquid_biopsy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q22349364> ;
  schema:citation <https://en.wikipedia.org/wiki/Liquid_biopsy>, <https://www.nice.org.uk/guidance/ng122/chapter/Diagnosis-and-staging>, <https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/>, <https://doi.org/10.1038/s41587-021-00981-w>, <https://doi.org/10.1126/scitranslmed.aai8545> ;
  onco:status "standard-of-care" ;
  onco:related <https://onco.cc/roadmaps/ctdna-tests/>, <https://onco.cc/technologies/cellsearch-ctc-count/>, <https://onco.cc/technologies/parsortix-ctc-harvest/>, <https://onco.cc/technologies/serum-tumour-markers/>, <https://onco.cc/technologies/cea-surveillance-colorectal/>, <https://onco.cc/technologies/multitarget-stool-rna-test/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/mced/> ;
  onco:companies <https://onco.cc/companies/guardant-health/>, <https://onco.cc/companies/foundation-medicine/>, <https://onco.cc/companies/natera/>, <https://onco.cc/companies/adela/>, <https://onco.cc/companies/aoa-dx/>, <https://onco.cc/companies/billiontoone/>, <https://onco.cc/companies/biodesix/>, <https://onco.cc/companies/c2i-genomics/>, <https://onco.cc/companies/cambridge-cancer-genomics/>, <https://onco.cc/companies/clearnote-health/>, <https://onco.cc/companies/delee/>, <https://onco.cc/companies/elypta/>, <https://onco.cc/companies/exai-bio/>, <https://onco.cc/companies/haystack-oncology/>, <https://onco.cc/companies/helio-genomics/>, <https://onco.cc/companies/inivata/>, <https://onco.cc/companies/insight-molecular-diagnostics/>, <https://onco.cc/companies/lucence/>, <https://onco.cc/companies/naveris/>, <https://onco.cc/companies/nonagen-bioscience/>, <https://onco.cc/companies/nucleix/>, <https://onco.cc/companies/numen/>, <https://onco.cc/companies/universal-dx/>, <https://onco.cc/companies/volitionrx/>, <https://onco.cc/companies/x-zell/>, <https://onco.cc/companies/belay-diagnostics/>, <https://onco.cc/companies/cnside-diagnostics/>, <https://onco.cc/companies/rgcc-international/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/vaf/> ;
  onco:trials <https://onco.cc/trials/nct07510828/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-sausen-ctdna-pancreatic-resection-nat-commun-2015/>, <https://onco.cc/key-papers/paper-groot-kras-ctdna-clinical-test-resected-pancreatic-ccr-2019/>, <https://onco.cc/key-papers/paper-pietrasz-ctdna-prognostic-pancreatic-ccr-2017/>, <https://onco.cc/key-papers/paper-cohen-ctdna-protein-liquid-biopsy-pancreatic-pnas-2017/>, <https://onco.cc/key-papers/paper-diaz-molecular-evolution-egfr-resistance-colorectal-nature-2012/>, <https://onco.cc/key-papers/paper-misale-kras-acquired-resistance-anti-egfr-colorectal-nature-2012/>, <https://onco.cc/key-papers/paper-nakamura-triumph-ctdna-pertuzumab-trastuzumab-her2-colorectal-nat-med-2021/>, <https://onco.cc/key-papers/paper-leighl-nile-cfdna-tissue-genotyping-ccr-2019/>, <https://onco.cc/key-papers/paper-aggarwal-plasma-genotyping-personalised-therapy-jama-oncol-2019/>, <https://onco.cc/key-papers/paper-oxnard-osimertinib-resistance-mechanisms-jama-oncol-2018/>, <https://onco.cc/key-papers/paper-lindeman-lung-molecular-testing-guideline-jto-2018/> ;
  onco:dependsOn <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/ngs-bioinformatics-software/>, <https://onco.cc/technologies/preanalytics-sample-stabilisation/> .